Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which fluid lifts better? trial tests two solutions for removing esophageal cancer without surgery

NCT ID NCT06077981

Recruiting now Disease control Sponsor: Instituto do Cancer do Estado de São Paulo Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This trial compares two liquids—hyaluronic acid and hydroxyethylamide—used to lift early-stage esophageal tumors before endoscopic removal. Doctors inject one of these solutions under the cancer to create a cushion, making it safer and easier to cut out. The study measures how much solution is needed, how long the procedure takes, and whether extra injections are required.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hyaluronic acid solution (TS-905 Blue Eye) and hydroxyethylamide solution (Voluven)
What this could lead to
If one solution proves superior, it could make endoscopic removal of early esophageal cancer faster and more efficient.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply broadly. The solutions are compared for technical performance, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOSCOPIC MUCOSAL RESECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal adenocarcinoma Esophageal Neoplasms esophageal squamous cell carcinoma neoplasm of esophagus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOSCOPIC MUCOSAL RESECTION ESOPHAGEAL NEOPLASMS HYALURONIC ACID

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto do Câncer do Estado de São Paulo

    RECRUITING

    São Paulo, São Paulo, 01246-000, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.